Follow Nuclera at:


Nuclera is a leading pioneer in developing cutting-edge benchtop protein printing technologies, empowering researchers and scientists to take control of biology through streamlined access to a next-day supply of proteins. The combination of three exciting Nuclera technologies: eProteinTM synthesis, eDNATM synthesis, and eDropTM digital microfluidics, in a deployable desktop bioprinting platform creates an unprecedented one-stop shop ecosystem providing consistent biological workflows, products, and information to its customers.

Headquartered in Cambridge, UK, Nuclera was founded in 2013 by four University of Cambridge PhD students and now has over 60 employees in the UK and USA.


Amadeus contact

Andrea Traversone